कोशिश गोल्ड - मुक्त
Why a ₹1-crore health cover matters—and how to buy it
Mint New Delhi
|June 13, 2025
What to watch out for while upgrading your health insurance policy amid rising medical cost
In 2016, Hyderabad-based Ankur Pathak's mother-in-law was diagnosed with Stage-III ovarian cancer, barely a month or two after undergoing angioplasty. The back-to-back medical emergencies left the family with limited funds to manage the treatment costs.
Though she had a reimbursement-based government health cover, the procedural delay and out-of-pocket expenses proved overwhelming. She passed away within three months, unable to continue chemotherapy.
The experience made Pathak realize the importance of having a strong insurance cover with adequate immediate support, regardless of employer-provided plans. He opted for ₹50 lakh base coverage, which would increase to ₹1 crore with no-claim bonuses.
More Indians are opting for ₹1-crore health covers as medical costs rise. Online insurance platform Policybazaar saw the number of such policies surge to 9,739 in 2024 from 4,427 policies in 2023. "In 2025, we've already sold 7,521 such policies by May," said Siddharth Singhal, health insurance head at Policybazaar, noting an 85% growth expectation for the year.
Why ₹1 crore?
Insurance advisors say ₹1 crore may feel excessive today, but five to 10 years down the line, it could be just about right. Medical inflation is pushing costs up fast. Data from the surgery-care company Hexa Health showed that the average severe illness claim in India doubles every 10 years.
For example, cancer treatment costs that hovered around ₹2-3 lakh in 2015 now average ₹4-6 lakh, and could touch ₹9 lakh by 2035. Meanwhile, a heart bypass that cost ₹3 lakh a decade ago may cost over ₹6 lakh by 2035.
While average treatment costs for severe illnesses provide a baseline, actual expenses often run significantly higher, especially in private hospitals and metro cities, where charges can be 2-3X the national average.
Additionally, illnesses rarely occur in isolation; follow-up treatments, diagnostics, and medications add recurring costs over time.
यह कहानी Mint New Delhi के June 13, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint New Delhi से और कहानियाँ
Mint New Delhi
CANADA'S STARTUP VISA: PUTTING LIVES ON HOLD
Legal uncertainty has left entrepreneurs stuck despite building businesses and putting down roots
8 mins
November 28, 2025
Mint New Delhi
Gupta pilfered from fraud, Trafigura says
Commodity trader Trafigura's lawyers accused Indian businessman Prateek Gupta on Thursday of siphoning off funds from an alleged $600 million metals fraud to prop up his struggling business empire.
1 min
November 28, 2025
Mint New Delhi
Why TCS is walking a tightrope
Tata Consultancy Services Ltd recently outlined an ambitious multiyear $6-7 billion investment plan to build artificial intelligence (AI)-focused data centres and is already making progress in that area.
2 mins
November 28, 2025
Mint New Delhi
Can a dictionary make sustainability simpler?
A new guide aims to bring clarity to sustainability in fashion but it has to be available to everyone, from designers to customers
3 mins
November 28, 2025
Mint New Delhi
Of Marathi plays, picnic in the park
A Mint guide to what's happening in and around your city
1 min
November 28, 2025
Mint New Delhi
Beyond the stock slump—Kaynes’ $1 bn aim is just the start
Shares of Kaynes Technology India Ltd have fallen about 25% from their peak of ₹7,705 in October, amid a management reshuffle and the expiry of the lock-in period for pre-IPO shareholders.
1 mins
November 28, 2025
Mint New Delhi
Avaada to invest ₹1 trillion in 5 years
Renewables-focused Avaada Group is aiming to invest ₹1 trillion across the country over the next five years as part of its expansion into both power generation and associated businesses.
1 min
November 28, 2025
Mint New Delhi
VentureSoul closes first debt fund at ₹300 crore
VentureSoul Partners has announced the close of its maiden debt fund at ₹300 crore, with plans to raise an additional ₹300 crore through a green shoe option by February 2026.
1 min
November 28, 2025
Mint New Delhi
New MF distributor incentives introduced
Mutual fund distributors will now earn additional incentives for bringing in first-time investors from B-30 (beyond the top 30) cities and for onboarding new women investors from any city, under Securities and Exchange Board of India's (Sebi) revised incentive framework.
1 min
November 28, 2025
Mint New Delhi
Catamaran to boost manufacturing bets
Catamaran is focused on a few areas in manufacturing, such as aerospace
2 mins
November 28, 2025
Listen
Translate
Change font size

